David Izadi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David Izadi

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013

Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic targetLiaquat S Verjee, Jennifer S N Verhoekx, James K K Chan, et al.

Science Advances|December 17, 2019

Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosisDavid Izadi, Thomas B Layton, Lynn Williams, et al.

American Journal of Human Genetics|September 9, 2017

A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in FibrosisMichael Ng, Dipti Thakkar, Lorraine Southam, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013

Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic targetLiaquat S Verjee, Jennifer S N Verhoekx, James K K Chan, et al.

Science Advances|December 17, 2019

Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosisDavid Izadi, Thomas B Layton, Lynn Williams, et al.

American Journal of Human Genetics|September 9, 2017

A Genome-wide Association Study of Dupuytren Disease Reveals 17 Additional Variants Implicated in FibrosisMichael Ng, Dipti Thakkar, Lorraine Southam, et al.

Pageof 2